• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Indurated Lesion on Child's Metacarpophalangeal Joint

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 6 No 7
Volume 6
Issue 7

A 6-year-old girl is brought for evaluation of an asymptomatic indurated erythematous lesion that erupted on the metacarpophalangeal joint of one hand 2 weeks ago. The patient has no history of trauma or exposure and is otherwise healthy.

THE CASE: A 6-year-old girl is brought for evaluation of an asymptomatic indurated erythematous lesion that erupted on the metacarpophalangeal joint of one hand 2 weeks ago. The patient has no history of trauma or exposure and is otherwise healthy.

(Answer and discussion on next page.)

Granuloma annulare is the correct answer.

DISCUSSION: This patient has granuloma annulare, a self-limited eruption whose cause is unknown. A low-potency topical corticosteroid was prescribed, and the lesion gradually improved over the course of several weeks.

Insect bites and contact dermatitis are pruritic. Eczema is pruritic and scaly. This lesion has none of the features that characterize warts, such as a pebbling texture and, in some cases, punctate hemorrhages that suggest thrombosed capillaries.

 

Online Poll

|

Online Survey

Case and images courtesy of David L. Kaplan, MD, University of Missouri Kansas City, University of Kansas.


 

Related Videos
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.